Skip to main content
Erschienen in:

09.12.2021 | original article

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU

verfasst von: Mag. Dr. Mario Karolyi, Erich Pawelka, Julian Hind, Sebastian Baumgartner, Emanuela Friese, Wolfgang Hoepler, Stephanie Neuhold, Sara Omid, Tamara Seitz, Marianna T. Traugott, Christoph Wenisch, Alexander Zoufaly

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2022

Einloggen, um Zugang zu erhalten

Summary

Background

Critically ill Coronavirus disease 2019 (COVID-19) patients have high rates of bacterial superinfection. Multiplex polymerase chain reaction panels may be able to provide useful information about the incidence and spectrum of bacteria causing superinfections.

Methods

In this retrospective observational study we included all COVID-19 positive patients admitted to our intensive care unit with suspected hospital-acquired pneumonia/ventilator-associated pneumonia (HAP/VAP) in whom the BioFire® Pneumonia Panel (PP) was performed from tracheal aspirate or bronchoalveolar lavage fluid for diagnostic purposes. The aim of our study was to analyze the spectrum of pathogens detected with the PP.

Results

In this study 60 patients with a median age of 62.5 years were included. Suspected VAP was the most frequent (48/60, 80%) indication for performing the PP. Tracheal aspirate was the predominant sample type (50/60, 83.3%).
The PP led to a negative, monomicrobial and polymicrobial result in 36.7%, 35% and 28.3% of the patients, respectively. The three most detected bacteria were Staphylococcus aureus (13/60, 21.7%), Klebsiella pneumoniae (12/60, 20%) and Haemophilus influenzae (9/60, 15%). Neither atypical bacteria nor resistance genes were detected.
Microbiological culture of respiratory specimens was performed in 36 (60%) patients concomitantly. The PP and microbiological culture yielded a non-concordant, partial concordant and completely concordant result in 13.9% (5/36), 30.6% (11/36) and 55.6% (20/36) of the analyzed samples, respectively.

Conclusion

In critically ill COVID-19 patients with suspected HAP/VAP results of the PP and microbiological culture methods were largely consistent. In our cohort, S. aureus and K. pneumoniae were the most frequently detected organisms. A higher diagnostic yield may be achieved if both methods are combined.
Literatur
25.
Zurück zum Zitat Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the American thoracic society. Clin Infect Dis. 2017;63(5):e61–e111. https://doi.org/10.1093/cid/ciw353.CrossRef Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the American thoracic society. Clin Infect Dis. 2017;63(5):e61–e111. https://​doi.​org/​10.​1093/​cid/​ciw353.CrossRef
30.
Zurück zum Zitat Allerberger F, Apfalter P, Bernig L, et al. Resistenzbericht Österreich AURES 2017. Antibiotikaresistenz und Verbrauch antimikrobieller Substanzen in Österreich. Wien: Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz; 2017. ISBN 978-3-85010-515‑6. Allerberger F, Apfalter P, Bernig L, et al. Resistenzbericht Österreich AURES 2017. Antibiotikaresistenz und Verbrauch antimikrobieller Substanzen in Österreich. Wien: Bundesministerium für Arbeit, Soziales, Gesundheit und Konsumentenschutz; 2017. ISBN 978-3-85010-515‑6.
Metadaten
Titel
Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
verfasst von
Mag. Dr. Mario Karolyi
Erich Pawelka
Julian Hind
Sebastian Baumgartner
Emanuela Friese
Wolfgang Hoepler
Stephanie Neuhold
Sara Omid
Tamara Seitz
Marianna T. Traugott
Christoph Wenisch
Alexander Zoufaly
Publikationsdatum
09.12.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 9-10/2022
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01990-0